Counting the benefits from U of M's million-dollar mouse
A genetically engineered mouse has brought in $1 million in licensing fees to the University of Minnesota for its use in cancer research.
The Minnesota Daily reports on the mouse and its unique advantages: Its plasma cells don't die and can be used as antibodies to help detect cancer cells.
The U of M licensed the antibodies to Cell Signaling Technology of Danvers, Mass., which sells antibodies to researchers. The U collects 4 perc ent of revenue from Cell Signalling's sale of antibodies; the 15-year-old…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Mark Reilly Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | Health Management | Pharmaceuticals | University of Minnesota